Revenue of BioNTech 2017-2023
In 2023, the annual revenue of biotech company BioNTech SE stood at 3.8 billion euros, compared to around 17.3 billion euros in the year before. This statistic illustrates the annual revenue of BioNTech SE worldwide from 2017 to 2023. On November 9th 2020, German biotech company BioNTech in cooperation with U.S. pharma giant Pfizer were the first to announce a proven COVID-19 vaccine to be ready for mass production by year-end.